Muhammad Umair Khan1, Shahjahan Shah2, Tahir Hameed3. 1. College of Pharmacy, Ziauddin University, 4-B Shahra e Ghalib, Clifton, Karachi, Pakistan. 2. Department of Pharmacy Services, Dr. Sulaiman Al Habib Hospital, Buraidah, Qassim, Saudi Arabia. 3. Department of Pharmacy, Health and Well-being, University of Sunderland, Sunderland, Tyne and Wear, UK.
Abstract
BACKGROUND: Hypertension is a silent killer, a time bomb in both the developed and developing nations of the world. It is one of the most significant risk factors for cardiovascular morbidity and mortality resulting from target-organ damage to blood vessels in the heart, brain, kidney and eyes. Adherence to long-term therapy for chronic illnesses like hypertension is an important tool to enhance the effectiveness of pharmacotherapy. OBJECTIVE: The two objectives of this study were to evaluate the extent and reasons of non-adherence in patients attended National Health Service (NHS) Hospital, Sunderland. MATERIALS AND METHODS: The study was conducted for 4 months in the out-patient department of NHS Hospital. A total of 200 patients were selected randomly for this study. Morisky's Medication Adherence Scale was used to assess the adherence rate and the reason of non-adherence. Data were entered and analyzed using Microsoft Excel 2010. RESULTS: The overall adherence rate was found to be 79% (n = 158). Adherence rate in females were low was compared with their male counterparts (74.7% vs. 85.7%). The higher rate of adherence was found in age group of 30-40 years (82%, n = 64). The major intentional and non-intentional reason of non-adherence was side-effects and forgetfulness respectively. CONCLUSION: Overall, more than three-fourth of the hypertensive participants were found to be adherent to their treatment. On the basis of factors associated with non-adherence, it is analyzed that suitable therapy must be designed for patients individually to increase medication adherence and its effectiveness.
BACKGROUND:Hypertension is a silent killer, a time bomb in both the developed and developing nations of the world. It is one of the most significant risk factors for cardiovascular morbidity and mortality resulting from target-organ damage to blood vessels in the heart, brain, kidney and eyes. Adherence to long-term therapy for chronic illnesses like hypertension is an important tool to enhance the effectiveness of pharmacotherapy. OBJECTIVE: The two objectives of this study were to evaluate the extent and reasons of non-adherence in patients attended National Health Service (NHS) Hospital, Sunderland. MATERIALS AND METHODS: The study was conducted for 4 months in the out-patient department of NHS Hospital. A total of 200 patients were selected randomly for this study. Morisky's Medication Adherence Scale was used to assess the adherence rate and the reason of non-adherence. Data were entered and analyzed using Microsoft Excel 2010. RESULTS: The overall adherence rate was found to be 79% (n = 158). Adherence rate in females were low was compared with their male counterparts (74.7% vs. 85.7%). The higher rate of adherence was found in age group of 30-40 years (82%, n = 64). The major intentional and non-intentional reason of non-adherence was side-effects and forgetfulness respectively. CONCLUSION: Overall, more than three-fourth of the hypertensiveparticipants were found to be adherent to their treatment. On the basis of factors associated with non-adherence, it is analyzed that suitable therapy must be designed for patients individually to increase medication adherence and its effectiveness.
Medication adherence is generally defined as the extent to which patient takes medication as prescribed by the medical practitioner.[1] Adherence depends on many factors as its prevalence has been shown by many studies in range from 0% to 100% respectively.[23] Non-adherence to prescribed medications has been a global problem as studies have shown that it has affected the most in patients with chronic illness such as diabetes and hypertension.[45] It is therefore an important issue which is directly linked with the management of chronic diseases as it has been established that the medication non-adherence lowers the treatment effectiveness and raises medication cost.[6] All stakeholders in healthcare system concerns the problem of non-adherence the most due to the scarcity of healthcare resource. The prevalence of non-adherence is affected by the choice of drug, use of concomitant medications, tolerability of drug and duration of drug treatment, which concludes from the analysis of multiple patient population.[7]Hypertension is a devastating chronic disease which has affected patients from every part of the world and is rank third as a cause of disability adjusted life years.[8] Joint National Committee VII states that there are more than 1 billion hypertensivepatients world-wide.[9] In Britain, however, prevalence of hypertension is 11.7% for ages; 14.4% for those aged more than 16 years; and 46% in those over 65 years of age.[10] Another study showed that age and sex-adjusted prevalence of hypertension was 28% in the North American countries and 44% in the European countries at the 140/90 mm Hg threshold.[11] In Asian country like Pakistan it was estimated that hypertension affects 18% of adults and 33% of adults above 45-year-old. In another report, it was shown that 18% of people in Pakistan suffer from hypertension with every third person over the age of 40 becoming increasingly vulnerable to a wide range of diseases.[12] With respect to gender, from 1999 to 2004, blood pressure control increased in men from 39% to 51% (P < 0.05) but did not change significantly in women (35-37%).[13] An important aspect in the treatment of hypertension is that patients who start with treatment should be prepared to take antihypertensive drugs for a life-long period. Imperfect execution of the dosing regimen or discontinuation of treatment because of, for example, side-effects of drugs will lead to a less effective treatment. Execution of the dosing regimen reflects the extent to which a patient takes his medication as prescribed and can be expressed by the term adherence or compliance.[14]Medication non-adherence among hypertensivepatients leads to severe consequences as it leads to poor controlled blood pressure, which increases the probability of cardiovascular (CV) problems.[15] Beta blockers and lipid lowering agents are most commonly prescribed drugs in hypertensivepatient and it has been reported that low adherence to these agents increase the risk of death in hypertensivepatients.[16] Similarly it has also been noted that the adherence rate of less than 75% with short acting anti-hypertensive drugs such as captopril and quinapril increases the risk of CV problems.Many researchers have tried to explore the complex relationship of medication adherence and its responsible factors. It has been mentioned that the association of medication adherence and socio demographic factors such as age, gender, ethnicity, education is weak and inconsistent.[17] However, recent evidences have shown the phenomenon could be understand by the conceptual distinction of intentional and unintentional medication non-adherence.[18] Health care society of almost every country is affected by this problem and it is important to identify this problem in one's community and evaluate its risk factors so that necessary interventions could be made to counter this rapidly rising problem. The objectives of this study were to evaluate the extent of non-adherence to antihypertensive medications and the reasons of non-adherence in patient registered with National Health Service (NHS) Hospital, Sunderland.
Materials and Methods
Study design and site
A prospective cross-sectional study was conducted in a NHS Hospital Sunderland. It is a community hospital located at the central region of the city. This is an Acute Trust providing a wide range of hospital services such as A and E, surgical and medical specialties, therapy services, maternity and pediatric care.
Study participants
Patients aged between 18 and 60, who have been diagnosed hypertension and are on anti-hypertensive (at least one) for last 6 months are included in this study. Pregnancy induced hypertensionpatients were excluded from the study. Patients diagnosed with hypertension but of less than 6 months duration were also excluded. Patients taking other drugs along with anti-hypertensive were not included in this study. Furthermore excluded were hypertensivepatients in an inpatient setting. Written consent was obtained prior to enroll participants in the study.
Sample size and sampling technique
The sample size was calculated as two by using Raosoft sample size calculator.[19] Convenience sampling technique was used to select participants. Respondents were selected daily by convenience sampling from the hypertensivepatients who attended outpatient clinic at NHS hospital.
Study instrument
The data collection tool used was a questionnaire adapted from Morisky self - reported medication adherence questionnaire relating to medication use and major reasons for non-adherence. It is 4-item questionnaire with a high reliability and validity, which has been particularly useful in chronic conditions like hypertension. It measures both intentional and unintentional adherence based on forgetfulness, carelessness, stopping medication when feeling better and stopping medication when feeling worse. The scale is scored 1 point for each “no” and 0 points for each “yes”. The total score ranges from 0 (non-adherent) to 4 (adherent).[20]
Study duration
The study was conducted for 4 months on participants who consented to participate in the study. It is important to consider the rights of respondents in every research; therefore the rights of respondents during the interviews were well-respected.
Data analysis
In Morisky's medication adherence scale questionnaire, a NO answer was allocated a score of 1 while a YES answer was given a score of 0. Hence a score of 4 would designate patient as fully adherence while a score of 0 would tag him as fully non-adherent. Similarly, a score of 1, 2 and 3 would specify patient as 25%, 50% and 75% adherent respectively. Patients who score 75% or more were considered as adherent while those who score less than 75% were termed as non-adherent.
Ethical approval
The study protocol was approved by the institutional research Ethics Committee. Furthermore, written consent was obtained from the respondents prior to participation in the study.
Results
A total of 200 participants were included in this study. The age of majority of the participants were between 30 and 40 (n = 78, 43.3%) while only 36 participants (16%) belonged to the age group of 50-60 [Table 1]. The result also showed that majority of the participant were female (n = 123, 61.5). The overall adherence rate was found to be 79% (n = 158), however only 36% (n = 72) of participants were fully adhering to the prescribed medications. The results showed that women were higher in numbers but their adherence rate was low was compared to their male counterparts as only 74.7% (n = 92) females were complying with the physicians order, of which those of fully adhere to the medicines were only 34.1% (n = 42). Conversely, the rate of adherence among males were high (85.7%, n = 66) although those of completely adhere to antihypertensive medicines were moderate in numbers (39%, n = 30) as shown in Table 2.
Table 1
Age distribution of study participants
Table 2
Estimation of Morisky's medication adherence scale by participants’ gender
Age distribution of study participantsEstimation of Morisky's medication adherence scale by participants’ genderMoreover, when medication adherence was linked with age groups of participants it was revealed that majority of participants aged between 30 and 40 and this class of age also possesses the higher rate of adherence (82%, n = 64). The least adhered age group was 18-30 (73.4%, 38). Interestingly, it was noted that participant who showed 100% adherence were mainly the oldest ones (i.e. 50-60 years) where 52.7% of participants of that group were absolutely adherent. The age group where absolute adherence was minimum was 40-50 years (19%, n = 7) as mentioned in Table 3.
Table 3
Estimation of Morisky's medication adherence scale by participants’ age
Estimation of Morisky's medication adherence scale by participants’ ageThe summary of the reasons of non-adherence is shown in Table 4. The reasons were divided into intentional and non-intentional non-adherence. 69% (n = 461) reasons mentioned by the participants who did not adhere to anti-hypertensive medicines were from intentional non-adherence and the major reason was the fear of side-effects (25.4%, n = 170) followed by inconvenience of taking medicines outside home (17%, n = 114). The least affecting intentional reason was fear of taking too many drugs at the same time (3.2%, n = 21). Furthermore, unintentional reasons account for 31% (n = 207) of non-adherence among hypertensivepatients. The non-intentional reason which is most frequently quoted by the patients was forgetfulness (22.4%, n = 149) while the reason which is least mentioned by the participants was cost of medicines (2%, n = 13).
Table 4
Reason of non-adherence to anti-hypertensive medication
Reason of non-adherence to anti-hypertensive medication
Discussion
Medication adherence is an important tool that can increase treatment effectiveness, however literature has shown that the rate of adherence in chronic disease like hypertension is very low and thus it is an important problem in the management of diseases which require long-term treatments.[21] The study revealed that the adherence rate is 79% with respect to antihypertensive treatment. It is higher than the medication adherence to antihypertensive medications reported in Egypt (74.1%), Malaysia (44.2%), Gambia (27%), Pakistan (57%) and Korea (61.1%) respectively.[2223242526] However it is lower than the medication adherence reported in Scotland (91%).[27] The difference is adherence rate could be due to cost of medical care and drugs, better care services and patient awareness about medication adherence.[28]Majority of the subjects participated in this study was between 30 and 40 years of age and the same age group shows maximum adherence (n = 64, 82%) to antihypertensive medications. However study conducted in North America showed that participants aged 30-40 years have low adherence when compared to elder ones. This discrepancy in result could be due to the reason that people of old generation have strong false belief such as fear of taking medication, side-effects of medication and so they are more often surrounded by the myths about their disease and medicines which could enhance rate of non-compliance.[29] Another possible reason for this difference in results could be due to the poor understanding of hypertension by this age group and the reluctance of accepting hypertension as a major threatening disease. Furthermore, in developing countries like Pakistan it was reported that older patient showed better compliance and it was mainly due to better social support structure supported by extended family system which have resulted in improved medication adherence.[25] Another study reported that inadequate health literacy, impaired cognition and decline in functions make elderly patients more prone to non-adherence.[30]This study also focused on associating medication adherence with gender and it was found that in male patients adherence to anti-hypertensive medications was on higher side as compared to their female counterparts (87.7% vs. 74.7%). This finding is in line with a study conducted in US, where sex was a significant predictor of adherence and men were more likely to be adherent then women.[31] In contrast, another study reported that the adherence rate between men and women were almost equal (61.4% vs. 60.9).[26] Similarly, few researches have shown that women are more likely to adhere to anti-hypertensive medications as most men are unaware to their hypertension and those whose who are aware are less likely to be taking their medication in a way as prescribed to them.[32] Furthermore, another study conducted on Chinese hypertensiveparticipants showed that female patients were positively associated with anti-hypertensive mediations.[33] The disparity of results among studies highlights the issue of sex differences in barriers to anti-hypertensive medication adherence. Poor sexual functioning and body mass index of 25 kg/m2 or more are the factors associated with low medication adherence to anti-hypertensive medications in males while dissatisfaction with communication with health care provider and depressive symptoms were associated with low adherence in females.[34]The study revealed that side-effect of medications, a form of intentional non-adherence, was the most common factor reported by participants. Many studies have supported this result by reporting that side-effect is one of the most important determinants of adherence in hypertensivepatient.[3536] It is therefore needed that health care provider must increase patients’ knowledge and understanding about the disease and the pharmacotherapy to increase the likelihood of medication adherence. The other approach could be to design a regime which caters an individual need of a patient in terms of affectivity and tolerability.Forgetfulness was the most reported non-intentional non-adherence factor. This result was consistent with the study conducted in US which reported the same. This could sometimes prove to be very hazardous for patients as they often rely on self-thought approaches and try to double the dose to compensate for the missed dose. This could amplify the danger of potential adverse effects of an individual drug. Necessary interventions must be made to overcome this issue. The possibilities could be a regular follow-up with effective counseling and by using real time medication monitoring system.[37]The urbanization effect has also influenced medication adherence as busy work schedules often force patient to omit doses while at work due to busy schedules and hence inconvenience is what they face while they are outside home. This study supports this statement as inconvenience of taking medicines outside home was the second most reported reason of intentional non-adherence. This result is also uniform with another past research which has shown that busy life-style is an important barrier to medication adherence in hypertensive population.[38]This study has some limitations such as; self-reporting was the only method employed in this study which is subjective in nature and may have under estimated the status of non-adherence when compared to objective measures of non-adherence such as pill count and prescription refills. However, Morisky et al. have reported that the self-report approach of measuring adherence is simple, inexpensive and useful way of identifying non-adherence in clinical setting.[20] This study did not include hypertensivepatient from in-patient setting and also excluded those who are taking medication for other co-morbidities. Hence the extent of generalizability is limited to similar patients; nonetheless the study provides some useful results which would be helpful in improving the rate of medication adherence in hypertensive population.
Conclusion
Overall, more than three-fourth of the hypertensiveparticipants were found to be adherent to their treatment. The study also revealed major factors such as side-effects, forgetfulness, busy schedule, inconvenience of taking medicine outside home are major barriers to anti-hypertensive medications. There is a need to tailor the therapy according to individual need of the patients to maximize the adherence and accomplish the eventual goal of controlling blood pressure.
Authors: Eric J MacLaughlin; Cynthia L Raehl; Angela K Treadway; Teresa L Sterling; Dennis P Zoller; Chester A Bond Journal: Drugs Aging Date: 2005 Impact factor: 3.923
Authors: Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He Journal: Lancet Date: 2005 Jan 15-21 Impact factor: 79.321
Authors: Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio Journal: JAMA Date: 2003-05-14 Impact factor: 56.272